Prescription Drug News and Research

RSS

Veterans Affairs San Diego Healthcare System initiates Pathway Fit clinical trial in obesity

Pathway Genomics Corporation, a San Diego-based genetic testing laboratory, has announced a clinical trial with the Veterans Affairs San Diego Healthcare System (VASDHS).

1 Sep 2012

Surveying Romney's health advisers; The pressures he faces if he wins

News outlets examine the role Micheal Leavitt and his followers will have on Romney's health policy and the expectation that a new president can change the health law quickly.

31 Aug 2012

Janssen receives FDA Priority Review for ZYTIGA sNDA to treat mCRPC

Janssen Research & Development, LLC, announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the supplemental New Drug Application (sNDA) for ZYTIGA (abiraterone acetate) administered in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy.

30 Aug 2012

Sleep disorder treatment: an interview with Dr Seth Lederman, President and CEO of Tonix Pharmaceuticals

Sleep disorders are a large area. We are focused on one particular type of sleep disturbance called “non-restorative” sleep. People with this problem do sleep, but they don’t wake up feeling refreshed or feeling that their sleep has had the restorative effects of healthy sleep.

29 Aug 2012

Obama, Romney trade more Medicare barbs

President Barack Obama went on the Medicare attack, using his weekly address to challenge Republican charges that he cut Medicare. Obama also launched a new ad saying that the Romney-Ryan ticket would end Medicare as it exists today. But the Romney campaign has Medicare messages of its own.

28 Aug 2012

First Edition: August 27, 2012

Today's headlines include reports about this week's GOP convention, the politics of Medicare and abortion, and the latest health policy news from the states.

27 Aug 2012

Prescription drug monitoring systems alert abuse

Electronic prescription monitoring programs may significantly improve drug-abuse detection and could alert clinicians to “doctor shopping,” say researchers.

24 Aug 2012

Proposed U.S. legislation would 'set the standard' for global efforts to combat counterfeit drugs

In this Forbes opinion piece, John Lechleiter, president and chief executive officer of Eli Lilly and Company, examines the business of counterfeit medicines, writing, "With global sales last year estimated as high as $200 billion, counterfeit medicine is big business, and it's growing."

24 Aug 2012

Romney vow to restore Medicare funding raises tough fiscal issues; GOP platform adds revamping of Medicare

In the short term, the Republican presidential candidate's promise to restore the Medicare cuts included in the health law would increase beneficiaries' costs. Meanwhile, the GOP draft platform embraces the Medicare changes advanced as part of Paul Ryan's House budget plan.

23 Aug 2012

FDA warns consumers about potential health risks of two natural dietary supplements

The U.S. Food and Drug Administration today issued a new warning to consumers about the potential health risks of two products marketed as natural dietary supplements for treating arthritis, muscle pain, osteoporosis, bone cancer, and other conditions.

22 Aug 2012

FDA extends action date for Pfizer’s tofacitinib NDA review

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has extended the action date by three months for the New Drug Application (NDA) for tofacitinib, an investigational oral treatment for adults with moderately to severely active rheumatoid arthritis (RA).

22 Aug 2012

Poll finds Calif. voters strongly support federal health law; Montana lawmakers consider Medicaid expansion

States are confronting a bevy of issues in implementing the health care law including gauging public support for the law, fights over a contraception coverage mandate, expanding Medicaid and assessing the Medicare prescription drug "doughnut hole."

22 Aug 2012

FDA committee to review NPS’ Gattex NDA in October

NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing therapeutics for rare gastrointestinal and endocrine disorders, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that its New Drug Application (NDA) for Gattex (teduglutide) will be discussed at the Gastrointestinal Drugs Advisory Committee meeting scheduled for October 16, 2012.

22 Aug 2012

Electronic PMP use may have impact on demand for drug treatment programs, painkiller abuse

A Rhode Island Hospital researcher has found that the use of electronic prescription drug monitoring programs (PMPs) may have a significant impact on the demand for drug treatment programs and how prescribers detect and respond to abuse of painkillers.

17 Aug 2012

George Washington University releases 'Obesity Drug Outcome Measures'

The George Washington University School of Public Health and Health Services (GW) today released a report representing consensus findings from a cross-section of stakeholders that could help transform the process used to evaluate interventions to treat obesity, a public health crisis that now affects one in three adults. The report, "Obesity Drug Outcome Measures," results from a stakeholder dialogue group convened by GW that, over a period of nine months, explored why development and approval of obesity drugs have proven so difficult.

15 Aug 2012

Viewpoints: Romney's gamble; The return of 'Mediscare;' Klein and Roy offer competing views on differences in Ryan, Obama plans

It doesn't take a political genius to see where the contest between President Obama and Mitt Romney is heading. With Rep. Paul Ryan on the Republican ticket, the campaign is looking at a full-throated debate over the future of Medicare. Are Romney and Ryan ready?

15 Aug 2012

AstraZeneca enters agreement with Pfizer for OTC NEXIUM

Pfizer Inc. today announced that it has entered into an agreement with AstraZeneca for the over-the-counter (OTC) rights for NEXIUM (esomeprazole magnesium), a leading prescription drug currently approved to treat the symptoms of gastroesophageal reflux disease (GERD).

14 Aug 2012

FDA extends PDUFA target action date for review of Santarus' UCERIS NDA

Santarus, Inc. today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) target action date for the review of the New Drug Application (NDA) for UCERIS (budesonide) tablets 9 mg for the induction of remission of mild to moderate active ulcerative colitis from October 16, 2012 to January 16, 2013.

14 Aug 2012

FDA extends PDUFA action date for NPS Gattex NDA

NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing therapeutics for rare gastrointestinal and endocrine disorders, today announced that it has received a communication from the U.S. Food and Drug Administration extending the Prescription Drug User Fee Act action date for its New Drug Application for Gattex (teduglutide) by three months to December 30, 2012.

13 Aug 2012

AbilTo, Aetna announce new program to help members with diabetes combat depression

The combination of depression and diabetes is common and potentially dangerous. People with depression can find it hard to make the lifestyle changes needed to manage diabetes. If not well managed, diabetes often leads to additional health issues, like heart, circulatory and kidney disease. Today, Aetna and AbilTo are announcing a new program to help members with diabetes combat depression and take control of their diabetes.

9 Aug 2012

Prescription Drug News and Research

Veterans Affairs San Diego Healthcare System initiates Pathway Fit clinical trial in obesity

Surveying Romney's health advisers; The pressures he faces if he wins

Janssen receives FDA Priority Review for ZYTIGA sNDA to treat mCRPC

Sleep disorder treatment: an interview with Dr Seth Lederman, President and CEO of Tonix Pharmaceuticals

Obama, Romney trade more Medicare barbs

First Edition: August 27, 2012

Prescription drug monitoring systems alert abuse

Proposed U.S. legislation would 'set the standard' for global efforts to combat counterfeit drugs

Romney vow to restore Medicare funding raises tough fiscal issues; GOP platform adds revamping of Medicare

FDA warns consumers about potential health risks of two natural dietary supplements

FDA extends action date for Pfizer’s tofacitinib NDA review

Poll finds Calif. voters strongly support federal health law; Montana lawmakers consider Medicaid expansion

FDA committee to review NPS’ Gattex NDA in October

Electronic PMP use may have impact on demand for drug treatment programs, painkiller abuse

George Washington University releases 'Obesity Drug Outcome Measures'

Viewpoints: Romney's gamble; The return of 'Mediscare;' Klein and Roy offer competing views on differences in Ryan, Obama plans

AstraZeneca enters agreement with Pfizer for OTC NEXIUM

FDA extends PDUFA target action date for review of Santarus' UCERIS NDA

FDA extends PDUFA action date for NPS Gattex NDA

AbilTo, Aetna announce new program to help members with diabetes combat depression

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News